• June 22, 2011
    Brussels--Click below to read the IFAH Press Release Alejandro Bernal Elected Chairman of International Federation for Animal Health - Europe more...
  • June 8, 2011
    Madison, N.J.--Pfizer Inc.’s Alpharma LLC subsidiary has decided to suspend sales in the United States of 3-Nitroâ (Roxarsone), a feed medicine used primarily in poultry production. Pfizer is taking this action in response to a request by the U.S. Food and Drug Administration (FDA) based on a recent study by the Agency. This study used a new method of testing for very low levels of inorganic arsenic in poultry tissue. The study found that themore...
  • May 11, 2011
    MADISON, NJ--Pfizer Animal Health and American Humane Association today announced a partnership to conduct a study on the impact of animal-assisted therapy on pediatric oncology patients, as well as on their parents, caregivers, siblings, and other close family members. The partnership — which includes a $282,000 grant from Pfizer and the Pfizer Foundation — exemplifies the strategic goal of both organizations to better quantify inmore...
  • March 7, 2011
    Durham, NC--Pfizer Poultry Health has introduced a broader, diversified portfolio of products and services with the acquisition of Alpharma LLC as part of Pfizer’s acquisition of King Pharmaceuticals. With the acquisition of Alpharma, Pfizer Poultry Health now offers a wider portfolio of products and services than any other global poultry healthcare provider. “The integration expands Pfizer Poultry Health’s product portfolio andmore...
  • January 28, 2011
    RALEIGH, N.C.--Visitors to the VIV Asia 2011 exhibition in Bangkok in March will be able to see the new, expanded portfolio from Pfizer Poultry Health, including one of its fully automated in ovo injection devices. Though the company has a wide range of health solutions covering the major poultry production diseases, its focus is on the individual farm, says Hari Yethirajyam Prasad, Asia-Pacific Regional Marketing Directormore...
  • January 26, 2011
    RALEIGH, N.C.--Pfizer Poultry Health is offering U.S. poultry producers a new option to optimize protection against one of the poultry industry’s most costly diseases, coccidiosis. Inovocox® EM1 is specially formulated to fight coccidiosis - the intestinal parasitic disease with an annual estimated global economic impact exceeding $3 billion. The new formulation accompanies the vaccine Inovocox® - launched in early 2009more...
  • December 29, 2010
    MADISON, N.J.--Pfizer Animal Health today announced an agreement to acquire Synbiotics Corporation (Pinksheets SYNB.PK), a privately held, Kansas City-based leader in the development, manufacture and marketing of immunodiagnostic tests for companion and food production animals. Veterinary immunodiagnostics, a methodology using antigen-antibody reaction to detect viruses or bacteria in animals, is a sector growing an estimated 8%more...
  • November 10, 2010
    DURHAM, N.C.--A new animal health research collaboration aimed at finding better ways of preventing and managing disease and advancing sustainable animal agriculture and welfare was announced today by Pfizer Animal Health and the Easter Bush Research Consortium (EBRC) – one of the largest veterinary research and education consortiums in Europe. The collaboration sets a new standard in animal health research and innovation and is backedmore...
  • July 7, 2010
    NEW YORK--As the global dairy industry continues to raise the bar on milk quality, Pfizer Animal Health recognizes a need for easy access to resources to help producers improve their milk quality decision-making. As a result, the company has launched a new online resource —www.milkqualityfocus.com— offering technical and actionable information on mastitis management and milk quality. "We understand the challenges dairy producers facemore...
  • June 11, 2010
    NEW YORK--Pfizer Animal Health today furthered its commitment to safe food from cattle by announcing a global licensing agreement with Epitopix that will expand access to its conditionally licensed Escherichia Coli Bacterial Extract vaccine* to U.S. cattle producers this fall. “Pfizer Animal Health supports cattle producers’ continuing strides against harmful bacteria, often the most frequent causes of food borne illnesses inmore...